Available Courses

AQDCE | Demystifying the Evolving Science and Potential Role of Incretins in T2D

Estimated Time
0.25 hr
Release Date
Jan 03, 2023
Expiration Date
Jan 02, 2024

AQDCE | Clinical Perspectives on Dual Checkpoint Blockade for mNSCLC

Estimated Time
0.25 hr
Release Date
Dec 28, 2022
Expiration Date
Feb 16, 2024

GVHD-E5 | ECHO Program: Atypical Manifestations of Chronic GVHD

Estimated Time
1.00 hr
Release Date
Dec 08, 2022
Expiration Date
Dec 08, 2023

Demystifying the Evolving Science and Potential Role of Incretins in T2D

Estimated Time
1.25 hr(s)
Release Date
Dec 07, 2022
Expiration Date
Jan 02, 2024

CLL-SLL/MTT Episode 1 - What You MUST Know About the Emerging Standard of Care for 1L Treatment of CLL and SLL

Estimated Time
0.50 hr
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023

CLL-SLL/MTT Episode 2 - Moving Towards Fixed-Duration Therapy in CLL and SLL

Estimated Time
0.50 hr
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023

CLL-SLL/MTT Episode 3 - Help Your Patients Navigate Risk-benefit Assessment, Choose the Best Therapy for Them, and Mitigate TEAEs

Estimated Time
0.50 hr
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023

NSCLC/MTT Episode 3 - Novel Therapeutics: Changing the Treatment Landscape for NSCLC

Estimated Time
0.25 hr
Release Date
Nov 29, 2022
Expiration Date
Nov 28, 2023

NSCLC/MTT Episode 4 - Practical Strategies for Preventing and Mitigating Toxicities of Targeted Therapy

Estimated Time
0.50 hr
Release Date
Nov 29, 2022
Expiration Date
Nov 28, 2023

NSCLC/MTT Episode 1 - The Evolution of Biomarker Testing: Revolutionizing Treatment of NSCLC

Estimated Time
0.50 hr
Release Date
Nov 22, 2022
Expiration Date
Nov 28, 2023

NSCLC/MTT Episode 2 - Biomarker Testing: Shaping Personalized Medicine

Estimated Time
0.25 hr
Release Date
Nov 22, 2022
Expiration Date
Nov 28, 2023

AQDCE | EASD: Potential Benefits of Incretins Beyond Glycemic Control in T2D

Estimated Time
0.25 hr
Release Date
Nov 22, 2022
Expiration Date
Oct 09, 2023

GVHD-E4 | ECHO Program: Bronchiolitis Obliterans

Estimated Time
1.00 hr
Release Date
Nov 02, 2022
Expiration Date
Nov 02, 2023

Build Your Own Case Study: A Glimpse at Optimal T2D Management: Enhancing Outcomes with GLP-1 RAs

Estimated Time
1.00 hr
Release Date
Oct 28, 2022
Expiration Date
Oct 27, 2023

Supporting Our Colleagues: Easing the Burden of Referrals for CAR-T in Aggressive B-cell Lymphomas

Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 29, 2023

Transitioning from Chemoimmunotherapy to More Targeted Approaches in MCL

Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 30, 2023

Mastering MRD for Prognosis and Treatment in ALL

Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 29, 2023

Potential Benefits of Incretins Beyond Glycemic Control in T2D

Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 29, 2023